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The hemopoietic system is regulated by many different 
humoral factors that are produced by blood cells such as 
macrophages, T and B lymphocytes, granulocytes, eosinophils, 
and mast cells, which are all capable of self renewal and 
differentiation. These humoral factors are glycoproteins that 
serve as cell mediators in immune response, inflammatory 
reactions, and hemopoiesis (Miyajima et al., 1992). These 
glycoproteins are collectively called cytokines which are not 
only involved in the immune response system but also affect 
the reproductive system. The biological activity of cytokines 
may differ a great deal among each other and also may overlap 
with . each other. Depending on their chemical structure, 
cytokine receptors can be shared by more than one cytokine or 
they can be very specific. Receptors have been found in many 
types of cells and these receptors can have high or low 
affinity for a specific cytokine. Receptors and mRNA for 
different cytokines can be found in the ovary. This suggests 
a role in ovulation since ovulation can be considered as an 
inflammatory reaction. 
that the presence of 
steroidogenesis. 
In addition, it has been hypothesized 
cytokines in the ovary can affect 
Based on this hypothesis many studies have been conducted 
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and subsequently the presence of blood cells (i.e., 
macrophages) in follicular fluid and in several follicular 
cells from different species has been reported. For instance, 
regulatory effects of interleukin-1 in rat (Adashi et al., 
1989), human (Barak et al., 1992a), and porcine (Fukuoka et 
al., 1989) granulosa cells have been reported. Other 
cytokines are produced by thecal and interstitial cells and 
exert an autocrine and paracrine effect. There have been no 
reports on the effect of cytokines relative to size of 
follicle in any species, and few reports on the effect of 
cytokines on bovine granulosa cell function. Therefore, the 
objective of these experiments was to determine the effects of 
some cytokines on in vitro estradiol production by granulosa 
cells obtained from small and large bovine antral follicles. 
CHAPTER II 
REVIEW OF LITERATURE 
Role of cytokines in the Immune 
and Inflammatory Reaction 
The immune system is composed of a network of 
interactions between cells that must communicate with each 
other for an effective immune response to occur against a 
stressful agent such as viral infections or more complex 
diseases. The non-self immune response has been known as 
the nonspecific antimicrobial system for self-limiting 
inflammation. The major histocompatibility gene complex 
(MHC) codes for cell surface glycoproteins necessary for the 
immune response. There are two classes of MHC. Class I MHC 
glycoproteins are found on all nucleated cells. Class II 
MHC glycoproteins are found in macrophages and B 
lymphocytes, as well as in granulosa cells in the ovary 
(Hill et al., 1990) in response to treatment with macrophage 
product (IFN-1) in vitro (Benyo et al., 1991). Recent 
studies have shown that the defense mechanism can be 
influenced by substances produced by cells involved in the 
immune response (Balkwin and Burk, 1989). Such substances, 
now called cytokines, are proteins or glycoproteins that can 
affect the cells that produce them or can affect other 
3 
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nearby cells. In other words, they can have an autocrine or 
paracrine effect in the cells involved in the immune 
response. Their primary structures consist of several 
hundred amino acids with N-glycosylations except for tumor 
necrosis factor a (TNFa; Harrison and Campbell, 1988). The 
cytokine family consists of interleukins (IL 1 to 12 and 
with a and B structures), interferons (IFN-a,B and~}, tumor 
necrosis factors (TNF a and B), granulocyte-macrophage 
colony stimulating factor (GM-CSF), and others have been 
identified. Cytokines are produced by monocytes, activated 
macrophages, T cells, B cells and fibroblasts (Babiuk et 
al., 1990), and their target cells are of wide variety. 
Harrison and Campbell (1988) categorized cytokine action in 
six ways: 1) T cell activation, growth and differentiation 
(IL-l, IL-2, IL-4, IL-5, IL-6, IFN-~), 2) B cell activation, 
growth and differentiation (IL-l, IL-2, IL-4, IL-5, IL-6, 
IL-7, IFN-~), 3} hematopoiesis (CSFs, IL-l, IL-3, IL-4, IL-
5), 4} inflammation (CSFs, TNFs, IFN-~, IL-l, IL-3, CSFs), 
5) mitogenic and metabolic effects on non-immune cells 
(TNFs, IFN-~, IL-l, IL-6) and 6) cytotoxicity (TNFs, IFN-~, 
IL-l) . A cytokine can enhance or inhibit the synthesis of 
other cytokines. For instance, IL-l and TNF stimulate each 
others release and these two stimulate IL-6 release from 
monocytes and macrophages (Nathan, 1987; Brouckaert et al., 
1989). IFN-~ has been recognized as one of the exogenous 
stimulatory signals of TNF receptor expression (Aggarwal et 
al., 1985). On the other hand, IL-10 which is aT cell line-
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derived cytokine, inhibits IL-l and TNF production (Ralph et 
al., 1992). Also, it has been reported that IL-10 inhibits 
the expression of IL-6, IL-8 , GM-CSF, and class II MHC in 
monocytes stimulated by IFN's (de Waal Malefyt et al., 
1991). 
Even though there are differences in the structure of 
cytokines, their actions appears to overlap in some cases. 
For instance, TNF and IL-l (Nathan, 1987; Spinas et al., 
1990) work synergistically in the activation of T and B 
cells, as well as monocytes, macrophages and other cells. 
IL-12 can enhance the induction of IFN-~ production by 
resting or activated peripheral blood natural killer (NK) 
cells and T cells {Chan et al., 1991). IL-12 and IFN-~ 
suppress T cell dependent synthesis of immunoglobulin E 
stimulated by IL-4 in vitro (Kiniwa et al., 1992). Also, 
IL-12 works synergistically with IL-2 in the generation of 
cytotoxic T cells and lymphokine-activated killer cells 
(Gubl~r et al., 1991). 
The concentration of cytokines in blood of normal 
animals is minimal. However, it is expected that their 
concentrations will increase during an immune reaction. For 
example, Ertel et al., (1991) measured the concentrations of 
IL-l in plasma from mice under normal conditions, sham 
surgery, and cecal ligation and puncture. He found that 
untreated animals had an IL-l concentration of 0.04 U/ml, 
while those animals that were treated had 0.42 U/ml and 
15.53 U/ml for sham surgery and ligation-puncture, 
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respectively, showing an increase in plasma IL-l occurs 
after an immune reaction. The same increasing tendency was 
observed for IL-6, having its maximum level of 0.83 Ujml, 
5.4 Ujml, and 62.1 U/ml for unmanipulated animals, sham 
surgery, and ligated-punctured animals, respectively. 
Another study reported the same increasing pattern of IL-6 
when measured in horse plasma, having much higher levels 
(10,128 Ufml) after 1000 ng of endotoxin/kg was applied r.v. 
to the horses (MacKay and Lester, 1992). Other studies, 
where IL-6 activity was tested in normal human beings or 
rodents, failed to detect circulating IL-6 activity (Ida et 
al., 1990; Van Goal et al., 1990; Ayala et al., 1991). 
TNF levels in peripheral circulation were undetectable 
when measured in normal mice (Ertel et al., 1991), horses 
(MacKay and Lester, 1992) and humans (Beutler, 1988). When 
the animals or individuals underwent surgery or were treated 
with endotoxin, the levels increased dramatically after 2 
hrs qf treatment (Lahdevirta et al., 1988, Beutler, 1988; 
Ertel et al., 1991; MacKay and Lester, 1992). In general, 
it appears that the body will react to a foreign agent 
through the immune response by producing cytokines in 
increasing levels. 
Biology of Cytokines 
This review will only cover the biology of IL-1, IL-2, 
IL-6, IFNs, and TNFs and their receptors. 
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Interleukin-1 
IL-l is a member of a group of immune mediators, 
secreted by a variety of immune and nonimmunocompetent cells 
(Lamedica et al., 1984; Dinarello, 1989). Two forms of IL-l 
have been cloned; IL-lB was cloned from human blood 
monocytes stimulated by endotoxin (Auron et al., 1984) and 
IL-la was cloned from the mouse macrophage line P388D 
(Lamedica et al., 1984). Subsequent to these findings, IL-
18 has been cloned in the cow, rabbit, rat and mouse and IL-
la has been cloned in human, rat, and rabbit (Dinarello, 
1989). There is 26% amino acid homology within the two 
human IL-l forms, and 25% of amino acid homology among the 
various animal species (Dinarello, 1989). 
In vitro, not only hematopoietic cells produce IL-l, 
but also endothelial cells, keratinocytes, smooth muscle 
cells, and renal mesangial cells transcribe large amounts of 
IL-l mRNA and translate IL-l protein (Barak et al., 1986; 
Auron et al., 1987; Dinarello, 1989; Deyerle et al., 1992). 
The control of IL-l translation is affected by other 
cytokines. IL-l-induced IL-l production (either IL-lS-
induced IL-la, or IL-la-induced IL-18) is suppressed by 
IFNs, whereas IFN-~ enhances IL-l synthesis after endotoxin 
or TNF stimulation (Ghezzi and Dinarello, 1988). It has 
been proposed that IL-l synthesis in monocytes is 
autoregulated not only by cytokines such as TNF, IL-l, and 
IFN-~ but also by prostaglandins produced by the same cells 
through a negative feedback mechanism (Favrot et al., 1989; 
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sung and Walter, 1991). Similarly, Knudsen et al., (1986) 
observed that IL-l synthesis is suppressed when murine cells 
were treated with prostaglandin~ (PG~). On the other 
hand, IL-l induced the release of PG~ mediated via 
induction of prostaglandin synthetase synthesis in a 
concentration and time dependent manner (Raz et al., 1988; 
Bull and Dowd, 1992). 
In addition to the inductive effect of IL-l on PG~, 
IL-l acts as a lymphocyte and thymocyte activating factor, 
proteolysis activating factor, mononuclear cell-activating 
factor, and may count for a majority of observed acute-phase 
changes in patients with bacterial infection, injury or 
chronic inflammatory disease (Favrot et al., 1989; 
Dinarello, 1989). IL-l also enhances T cell proliferation, 
augments the response of T, B and NK cells, stimulates the 
production of IL-6, IFN-~, and IL-2 by T cells, and augments 
the expression of IL-2 receptors in murine thymocyte cells 
(Dinarello, 1989). 
Holtmann and Wallach, (1987), found that IL-l decreased 
the vulnerability of the cells to the cytolytic effect of 
TNF by inducing a decrease in TNF receptors in human 
foreskin fibroblasts and svso and HeLa cell lines. on the 
contrary, Fischer et al., (1992) stated that IL-l 
contributes to and potentiates TNF-a induced cardiovascular 
collapse in baboons through their synergistic effect. 
Reasons for this discrepancy are unclear but may be due to 
different effects of IL-l depending on the type of cell, 
culture system, species, or the methods used to analyze the 
cytokines. 
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It is thought that IL-l may play an important role in 
reproduction since its presence has been documented in the 
human (Khan et al., 1980) and porcine (Takakura et al., 
1989). Furthermore, it has been revealed that IL-l possess 
potent antigonadotropic (Fukuoka et al., 1989; Gottschall et 
al., 1989; Yasuda et al., 1990), or steroidogenic (Nakamura 
et al., 1990) properties. In addition to these properties, 
IL-l has been established as a mediator of inflammation 
(Dinarello, 1989) and since ovulation may constitute an 
inflammatory-like reaction, IL-l may play an intermediary 
role in the ovulation process (Nothnick and Pate, 1990; 
Hurwitz et al., 1991; Bull and Dowd, 1992; Kokia et al., 
1992). But the importance of the effects of IL-l likely 
depends on the level of IL-l receptors found in a particular 
cell type. 
studies on IL-l receptors have focused on two cell 
types: murine thymoma cells and fibroblasts. Two types of 
receptors (I and II) have been found. Type I IL-l receptors 
are present on T cells, B cells, fibroblasts, epithelial 
cells, and keratinocytes. Evidence indicates that type I 
IL-l receptors are subject to up-regulation by forskolin and 
are cAMP dependent (Bonin et al., 1990; Hurwitz et al., 
1992) but this dependency is not yet clear. Type II IL-l 
receptors are present on B cells and macrophages (Hurwitz et 
al., 1992). The molecular structure of type II IL-l 
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receptor belongs to the immunoglobulin superfamily 
(Dinarello, 1989). The IL-l receptors are specific in that 
they do not recognize other cytokines. However, these 
receptors do not distinguish between IL-la or IL-lB 
(Dinarello, 1989; Miyajima et al., 1992). Recent studies 
have found that the expression of both types of IL-l 
receptors are abundant in nonlymphoid organs such as brain, 
pancreas, uterus, and skin (McMahan et al., 1991; Deyerle et 
al., 1992). In addition, IL-l receptor transcripts were 
detected in RNA from whole ovaries and follicular aspirates 
taken from women undergoing in vitro fertilization and 
embryo-transfer. Later, Hurwitz et al., (1992) found that 
mRNA for IL-l receptors was detectable in cultured human 
granulosa and thecal cells. Because of the multiple effects 
of IL-l on ovarian cells it is thought that IL-l receptors 
are present in murine (Gottschall et al., 1987; Kasson and 
Gorospe, 1989) and porcine (Fukuoka et al., 1989; Yasuda et 
al., .1990) granulosa cells. 
Interleukin-2 
IL-2 is secreted by T lymphocytes and was first 
identified as aT cell growth factor (Morgan et al., 1976; 
Robb, 1984), which allows the clonal expansion in vitro ofT 
cells activated by antigens. The induction of IL-
2 in T cells and T cell lines consist of a synergistic 
effect of IL-l with antigens, mitogens, ionophores, or 
activators of protein kinase c (PKC) through two induction 
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signals. The first signal involves an increase in cytosolic 
calcium, and the second signal involves increase in the·· PKC 
activity (Dinarello,l988; Oyaizu et al., 1992). 
IL-2 is one of the most powerful activators of human 
monocytes in vitro which respond to IL-2 by producing 
hydrogen peroxide (Holter et al., 1987). Also, IL-2 induces 
TNF-a mRNA, expression of IL-l~ mRNA, microbial and 
tumoricidal activity, and IL-6 mRNA and IL-6 induction in 
human monocytes (Musso et al., 1992}. IL-2 has a key role 
in the induction of immune response by activating T 
lymphocytes, NK cells, B lymphocytes, and in the production 
of other cytokines (Harrison and Campbell, 1988). IL-2 is 
also capable of the stimulating lymphokine-activated killer 
cells {LAK) which are able to destroy specific tumoral cells 
without damaging normal cells through a mechanism called 
11 non-MHC restricted" (Grimm et al., 1982; Hatakeyama et al., 
1989). Because of its function in the immune system, IL-2 
has been widely used in the treatment of cancer patients. 
There are endogenous factors that induce IL-2 synthesis (IL-
l, IL-5, and IL-6), as well as factors that inhibit the 
induction of receptors for IL-2 on T cells therefore 
limiting the effect of IL-2 (Naito, 1988; Hatakeyama et al., 
1989). 
IL-2 receptors have been characterized on resting T 
cells, NK cells, and some B and T cell lines (Espinoza-
Delgado, 1992; Hatakeyama et al., 1989). There are two 
subunits of the IL-2 receptor: p55 (a) and p75 (~) kDa 
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glycoprotein, having low and medium affinity 1 respectively 
in accordance to binding ability to IL-2. These two combine 
to form a high affinity receptor (aB). IL-2 regulates IL-2 
receptor B mRNA 1 and IFN-~ induces IL-2 receptor a mRNA 
(Naito et al., 1989; Hatakeyama et al., 1989). Also, IL-l 
is considered one of the factors promoting the expression of 
IL-2 receptors (Nathan, 1987). It has been shown that the 
intermediate and high affinity IL-2 receptors can both 
internalize IL-2 into the cell (Hatakeyama et al., 1989). 
Interleukin-6 
IL-6 is a protein of 184 amino acids with potential N-
glycosylation sites and 4 cystein.e residues, showing a 
significant homology (25%) with granulocyte-colony 
stimulating factor 1 a growth factor involved in the immune 
response (Hirano et al., 1986), suggesting they may have 
some functional similarities. Comparison of the eDNA 
sequences of human IL-6 and murine IL-6 shows a homology of 
65% at the DNA level and 42% at the protein level (Tanabe et 
al. 1 1988). IL-6 is secreted by T lymphocytes, B 
lymphocytes, monocytes, fibroblasts, keratinocytes, 
endothelial cells, granulosa cells and several tumor cells 
{Kishimoto, 1989; Harrison and Campbell., 1989; Gorospe et 
al., 1992). IL-6 production in T cells is induced by T cell 
mitogens and by antigenic stimulation in the presence of 
direct contact with macrophages (Helfgott et al., 1987). 
Its production is also enhanced by lypopolysaccharides (LPS) 
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(Horii et al.,l988), IL-l, tumor necrosis factor (TNF), and 
INF-13 (Kishimoto, 1989). Glucocorticoids negatively 
regulate IL-6 gene expression in various cells types 
(Helfgott et al., 1987), and immunomodulatory eicosanoid 
PG~ is involved in the regulation of IL-6 release during 
sepsis which is the presence of pathogenic organisms in the 
blood (Ertel et al., 1991}. 
IL-6 plays an important role in the final 
differentiation of B cells into antibody producing cells 
(Hirano et al., 1985; Muraguchi et al., 1988). There is 
also evidence that IL-6 induces the expression of IL-2 
receptors (Noma et al., 1987), induces IL-2 production in 
mitogen-simulated T cells and thymocytes (German et al., 
1987) and up-regulates IL-3 receptor expression in murine 
spleen cells (Kishimoto, 1989). In the presence of human 
and murine thymocytes, IL-6 induces proliferation and 
cytotoxicity ofT cells (Takai et al., 1988; Okada et al., 
1988}. In the systemic reaction of inflammation or injury 
called acute phase response, IL-6 is involved in the 
induction of the production of several proteins in vivo such 
as fibrinogen, alpha-1-antichymotrypsin, and alpha-1-acid 
glycoprotein (Nijtein et al., 1987) showing a synergistic 
effect with glucocorticoid (Castell et al., 1988) on the 
induction of acute phase proteins. In vivo studies with 
rats demonstrated that the application of IL-6 caused an 
increase in the plasma levels of adrenocorticotropic hormone 
(Naito et al., 1988) through stimulating the release of 
corticotropin-releasing hormone. Also, there is evidence 
that IL-6 is involved with the nerve growth factor system 
(Kishimoto, 1989). Therefore, IL-6 appears to be involved 
with the immune response as well as the neuro-endocrine 
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system of the body. In general, IL-6 provides multiple 
signals on various tissues and cells that can be divided 
into three categories: 1) induction of differentiation or 
specific gene expression such as Ig induction in B cells or 
acute phase proteinsi 2) stimulation of cell growth; and 3} 
inhibition of cell growth. Why IL-6 provides such a variety 
of signals is unclear but this may be related to the 
differential expression of receptor levels on various cell 
types. 
The IL-6 receptor consists of two polypeptide chains, a 
ligand binding chain and non-ligand binding, signal 
transduction chain having a sequence homology to the Ig 
superfamily and having no tyrosine kinase domain. The 
deteqtable number of IL-6 receptors ranges from 100 to 
20,000 sitesfcell depending on the cell type (Taga et al., 
1987; Kishimoto, 1989}. IL-6 receptors are expressed in 
various cells such as activated B cells, resting T cells, B 
lymphoblastoid cell lines, myeloma cell lines, hepatoma cell 
lines, and monocytes cell lines (Kishimoto, 1989; Miyajima 
et al., 1992). The overall amino acid homology between 
human and mouse IL-6 receptor is 54% (Sugita et al., 1990). 
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Interferons (IFNs) 
Interferons are proteins with a molecular weight of 16-
27 kDa (Pestka et al., 1987). These proteins are classified 
as type a, type B, and type 1 according to their 
antigenicity. IFN-a and IFN-8 were identified as products 
of virus-infected cells such as leukocytes and fibroblasts, 
whereas IFN-1 is produced as primary response of T 
lymphocytes to mitogenic stimulation (Morris, 1988; Xiao and 
Findlay, 1991). IFN-1 is considered to be structurally 
different from the IFN-a and IFN-B (Gray and Goeddel, 1982). 
Human IFN-a is part of a family of multifunctional cytokines 
consisting of at least 15 subtypes with 78-98% amino acid 
homology among the subtypes (Overall and Hertzog, 1992) and 
there is 45-75% homology of IFN-a between species (Roberts, 
1989). Human IFN-a has considerable variation in its 
specific activity on human cells, and has only a weak cross-
reaction on mouse cells (Rehberg et al., 1982). In cattle, 
a pregnancy specific protein (bTP-1), produced by the 
conceptus during the first days of pregnancy, is a member of 
the 172 amino acid IFN-aii family (Imakawa et al., 1989; 
Stewart et al., 1990) 
IFNs have multiple activities including antiviral, 
antiproliferative, and differentiative activity (Petska et 
al., 1987). IFNs have been shown to modulate the activity 
of T and B lymphocytes, NK cells, macrophages, and other 
cells involved in the immune response (Hill et al., 1979; 
Capon et al., 1985; Billiau, 1988). IFNs are known to 
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inhibit the growth of tumoral cells (Wallach et al., 1982; 
Pace et al.,1983; Lee et al. 1 1986) as well as normal cells. 
IFNs induce the production of ILs and increase TNF activity 
(Tsujimoto et al., 1986), which may be related to other 
effects and not directly to IFN. IFN-a was first found in T 
cells (Gutterman, 1982) and in chronic myeloid leukemia by 
Talpaz et al. (1986). IFN-a shares some sequence homology 
at both the amino acid and nucleotide level with 
approximately a 25% amino acid identity to IFN-B. 
It has been shown that a systematic administration of 
IFN-a and IFN-~ can inhibit lipopolysaccharide-induced 
reaction, which is an immune reaction that causes the 
manifestation of increase in temperature, inflammation or 
shock, suggesting that IFNs down regulate inflammatory 
responses that could be detrimental to the animal (Billiau, 
1987). IFN-~ also activates eosinophils and rnacrophages 
(Lambert and Paulnock, 1989). IFN-~ produced by murine T 
help.er-1 cells suppressed the IgE-mediated allergic response 
that other cytokines enhanced (Mosmann and Coffman, 1989). 
Also, IFN-~ treatment increased the number of available TNF 
receptors without affecting the apparent affinity and 
stimulated synthesis of mRNA for the TNF receptor protein 
(Tsujimoto and Vilcek, 1986; Tsujimoto et al., 1986) in 
human HeLa cell cultures. IFN-~ increased the sensitivity 
of human cancer cells to TNF (Ruggiero et al., 1986; 
Brouckaert et al., 1989}, and consequently suggests a 
synergistic cytotoxic effect with TNF. Local application of 
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IFN-~ intensifies the response within an inflammatory focus 
and appears to have an important role in the regulation of 
acute phase response and uncontrolled inflammatory 
reactions, which may lead to pathological alterations to 
host tissue (Sordillo and Peel, 1992). The presence of IFNs 
in several organs of normal individuals suggests that IFNs 
are important in normal physiology (Tovey et al., 1987), 
especially in maintaining pregnancy (Roberts, 1989). There 
is also evidence that IFNs may play an important role in 
modulating the ovarian function because of their effects on 
ovarian cells (Orava et al., 1985; Gorospe et al., 1988; 
Xiao and Findlay, 1991}. 
Competitive binding of human IFNs on human cells seems 
to indicate that all human IFN-a and IFN-B share a common 
receptor, while IFN-~ is recognized by a distinct receptor 
system (Merlin et al., 1985; Uze et al., 1990; Miyajima et 
al., 1992; Senda et al., 1992). There is no homology 
between IFN-~ and IFN-a or IFN-B. The number of IFN 
receptors is usually in the order of 102 to 103 per cell, 
which is about 100-fold less than that for hormones or 
growth factor receptors (Kishimoto, 1989). IFN receptors 
are present in all tissues and even on the surface of most 
interferon-resistant cells (Aguet and Mogensen, 1983). IFN 
receptors are species specific, and therefore, each species 
may have its own specific signal transduction (Miyajima et 
al. , 1992) . 
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Tumor Necrosis Factor (TNF) 
TNF is a polypeptide with a molecular weight of 17 kDa 
(Beutler and Cerami, 1987). Two forms of TNF have been 
identified: TNF-a and TNF-B which have a 28% amino acid 
homology (Sherry and Cerami, 1988). TNF-a is produced by 
activated macrophages, and TNF-B (or lymphotoxin} is 
produced by T lymphocytes (after stimulation by specific 
antigens) , endothelial cells, and keratinocytes (Aggarwal et 
al., 1985; Beutler and Cerami, 1987i Favrot et al., 1989). 
TNF-a is thought to play a major role in the cachexia which 
is a general emaciation occuring in the course of a chronic 
infection and the physiopathologic manifestation of shock 
produced by sepsis (Schmid et al., 1985; Beutler et al., 
1985; Dinarello, 1989; Favrot et al., 1989), as well as 
anorexia, diarrhea, hypertension and disseminated 
intravascular coagulation that may cause death (Bielefeldt 
et al., 1984; Waage et al., 1987; Lantz et al., 1991). TNFs 
induce the synthesis of monokines such as IL-lB and IL-6 
which also have been implicated in the pathophysiology of 
infections (Dinarello et al ., 1988). The effect of TNF or 
IL-l on a variety of cells in vitro as well as systemic 
effect in vivo are often biologically indistinguishable 
because of their synergistic action (Dinarello, 1989). TNF 
also synergizes with IFN-~ in their cytotoxic action on 
tumor cells (Tsujimoto et al., 1986). TNF activates 
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eosinophils and therefore plays a role in the response of 
parasitic infection (Favrot et al., 1989). Also, it has 
been documented that TNF stimulates the Na+/H+ antiporter in 
human fibroblasts causing intracellular alkalinization and 
further cell proliferation (Yiul-Lee et al., 1992). 
Production of TNF has been shown to be down-regulated by 
PGEz through a negative feedback mechanism during sepsis 
(Ertel et al., 1991}. Like the other cytokines, TNF is also 
involved in the endocrine system, modulating steroidogenesis 
in the ovary of various species (Adashi et al., 1990; 
Fukuoka et al., 1992). All these functions of TNF are 
thought to be mediated by specific binding sites or 
receptors. 
Two different receptors for TNF have been found: a 55 
kDa and a 75 kDa protein, expressed at low levels in various 
murine cells. Both receptors bind TNF-a and TNF-B equally 
well (Miyajima et al., 1992). The amino acid homology 
between the human and murine TNF receptor is 75% (Harrison 
and Campbell, 1989). About 1000 receptors per cell were 
reported in binding assays with L cells and murine TNF (Kull 
et al., 1985). High affinity TNF receptors are present in a 
variety of normal and transformed tumor cells (Miyajima et 
al., 1992). TNF receptors are also present in porcine 
granulosa cells (Veldhuis et al., 1991). 
TNF receptors appear to be up-regulated by other 
cytokines such as IFN-r in human HeLa 098 cell cultures 
(Ruggiero et al., 1986; Tsujimoto et al., 1986). Studies 
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done with rat cell cultures reported that the three forms of 
IFN (a, B and /) increased TNF receptor numbers without 
affecting their affinity (Scheurich et al., 1986; Ruggiero 
et al., 1986; Tsujimoto and Vilcek, 1986; Scheurich et al., 
1989). It was also reported that IL-18 as well as tumor-
promoting phobol diester can down-regulate TNF binding by 
decreasing the number of TNF receptors (Holtmann and 
Wallach, 1987; Holtmann et al., 1991; Bethea et al., 1992). 
This regulation might be modulated by the number of IL-l 
receptors or by enhancing phosphorylation of protein kinase 
c or other types of proteins. Scheurich et al. (1989) 
identified protein kinase A (PKA) as one of the endogenous 
regulatory elements that control TNF receptor expression by 
a mechanism independent of and antagonistic to the 
previously described PKC-mediated control of receptor 
affinity, enhancing TNF receptor synthesis. 
Presence of Immune Cells in the ovary 
As reviewed above, it has been shown that white blood 
cells such as macrophages, T lymphocytes and others, under 
stimulation or activation, produce certain substances called 
cytokines which are related to the immune response and 
inflammatory reactions. It was suggested that a modified 
inflammatory process was involved in ovulatory rupture of 
the follicular wall (Lipner, 1988; Espey, 1992). White 
blood cells have been viewed as moderators of acute 
inflammatory response and the presence of white blood cells 
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in the ovary has been reported (Nakamura et al., 1987; 
Katabuchi et al., 1989; Loukides et al., 1990; Gaytan et 
al., 1991; Fukumatzu et al., 1992; Brannstrom et al., 1993). 
Historically, macrophages have been considered for their 
phagocytic activity during ovulation, follicular atresia, 
and luteal regression (Lobel and Levy, 1968; Leavitt et al., 
1973; Bagavandoss et al., 1988). In addition to their 
phagocytic role, macrophages secrete a wide variety of 
products, including growth factors, arachidonic acid 
metabolites, neutral proteases, and some cytokines. Not 
only macrophages produce cytokines, but also white blood 
cells that infiltrate the follicle or corpus luteum 
(Standaert et al., 1991). Any of these secretory products 
could influence ovarian function by regulating granulosa, 
thecal, and luteal cell growth, and/or steroidogenesis. 
Ovarian Follicles 
. The presence of macrophages in the ovary has been 
documented by several authors. These macrophages likely 
produce cytokines that may act as autocrine or paracrine 
modulators of ovarian cell functions. Loukides et al., 
(1990) found that 5 to 15% of the resident nucleated cells 
in human follicular fluid were monocytes and macrophages and 
that there appears to be a stable population of these cells 
within the. microenvironment of the ovarian follicle during 
the follicular and luteal phases. Katabuchi et al., (1989} 
have suggested that in the small antral follicles of the 
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human ovary there are relatively few macrophages but numbers 
increase dramatically in the developing follicle and 
immediately prior to ovulation. Similarly, quantitative 
analysis of immune cells such as macrophages in ovarian 
follicles from cyclic cows (Nakamura et al., 1987), cyclic 
rats (Gaytan et al., 1991; Brannstrom et al., 1993), and 
immature rats (Fukumatzu et al., 1992) indicated that a 
significant number of white blood cells are present in 
healthy antral and mature follicles. It is suggested that 
the resident ovarian white blood cells may constitute 
potential in situ regulation in the ovary (Bagavandoss et 
al., 1988; Harrison and Campbell, 1988; Adashi et al., 
1989) . 
Corpus Luteum 
The migration of macrophages, lymphocytes, rnonocytes, 
and NK cells into the regressing corpora lutea has been 
observed in many species of animals, including humans and 
cattle (Lei et al., 1991; Standaert et al., 1991; Wang et 
al., 1992a). Lymphocytic infiltration in the cyclic bovine 
corpus luteum was reported (Lobel and Levy, 1968) and the 
migration of eosinophils occurred before either functional 
or structural luteal regression in sheep (Murdoch, 1987). 
This infiltration did not occur to the same extent when 
compared pregnant and cyclic animals. Macrophages were 
identified in mouse corpora lutea (Kirsch et al., 1981) at 
the time when the luteal cells were secreting large amounts 
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of progesterone and there was no evidence of luteolysis 
which would affect steroid secretion. Similarly, Standaert 
et al., (1991) found that macrophages are the predominant 
blood cell type present in luteal tissue during specific 
stages of the porcine corpus luteum. Other studies have 
reported the presence of white blood cells in rabbit corpora 
lutea (Bagavandoss et al., 1990), demonstrating that the 
number of macrophages increased greatly with the regression 
of the corpus luteum. Lei et al., (1991) found an 
increasing number of macrophages in the human corpus luteum 
from early to late luteal phase, suggesting that macrophages 
could play dual function; i.e., luteotropic in early and 
mid-luteal phases and luteolytic in late luteal phase. 
These authors also determined that the number of luteal 
fibroblasts decreased in maximally functioning corpora lutea 
and then greatly increased in regressing corpora lutea. In 
summary, various blood leukocytes, most significantly 
mac~ophages, lymphocytes, and eosinophils, differentially 
migrate into specific structures of the ovary at specific 
stages of the estrous cycle of most mammals. These findings 
suggest that white blood cells may be involved in some 
reproductive events such as ovulation, differentiation of 
follicular tissue during luteinization, and luteal 
regression. 
Presence and Action of cytokines in the Ovary 
In the same way white blood cells can be detected in 
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the ovary, cytokines (mostly IL-l, IFNs, and TNF) can be 
found in the ovary. The presence of cytokines in different 
parts of the ovary created the need to identify the 
functions of these factors in relationship to the cells 
where they were found and their role in reproduction. 
Cytokines in the Follicle 
Interleukins. Human follicular fluid contains 
considerable levels (1.58 fmol/0.1 ml) of IL-l with a 
significant positive correlation between follicular fluid 
IL-l and progesterone levels (Barak et al., 1992a). On the 
contrary, Fukuoka et al., (1989) reported that IL-l markedly 
inhibited progesterone secretion by immature porcine 
granulosa cells, and the responsiveness of the cells in 
terms of cell growth and basal progesterone secretion were 
greater in immature granulosa .cells than in differentiated 
or mature cells, suggesting that granulosa cells lose their 
res~onse to IL-l as they differentiate to luteal cells. 
Fukuoka et al., (1992) found that IL-la, IL-18, and IL-2 had 
no significant effect on human chorionic gonadotropic (hCG)-
stimulated progesterone secretion in luteinized human 
granulosa cells. In cultured rat granulosa cells, IL-6 also 
inhibits FSH-induced progesterone production (Gorospe et 
al., 1992). IL-l did not affect basal or LH-stimulated 
progesterone secretion by human luteal cells (Barak et al., 
1992a} as in previous studies in porcine (Fukuoka et al., 
1989) and human granulosa cells (Wang et al., 1991}. 
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Barak et al., (1992b) found that IL-l inhibited (hCG)-
stimulated aromatase activity and estradiol production by 
human granulosa cells. Similarly, IL-1a inhibited follicle-
stimulating hormone (FSH)-induced estradiol secretion by 
human granulosa cells (Yasuda et al., 1990; Fukuoka et al., 
1992), suggesting a role for this cytokine as a local 
antiluteolytic agent since IL-l also inhibits morphological 
luteinization induced by LH {Fukuoka et al., 1989). IL-2 
had no effect on estradiol secretion (Fukuoka et al., 1992). 
There are no previous studies reported that have measured an 
IL-6 effect on estradiol production by granulosa cells. 
IL-l inhibited FSH-stimulated cyclic-adenosine 
monophosphate (cAMP) generation by 80 to 90%, but IL-l did 
not affect hCG-stimulated cAMP generation in cultured human 
luteinized granulosa cells (Fukuoka et al., 1992). In 
contrast, Sjogren et al., (1991) reported that IL-l alone 
did not significantly increase cAMP accumulation compared to 
the.control, but IL-l at a concentration of 50 IU/rnl 
enhanced LH-induced cAMP release by human granulosa cells. 
Similar results of enhanced LH-stimulated cAMP by porcine 
granulosa cells were found by Yasuda et al., (1990). IL-l 
also shows the ability to decrease androstenedione 
production by thecal cells (Hurwitz et al., l991a), and this 
effect may be due to an inhibition of steroidogenic 
transformations catalyzed by 17a-hydroxylasej17-20 lyase. 
IL-l may also play an important part in the process of 
follicular rupture at ovulation; it may stimulate PGE2 
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production by monocytes and in turn its own production is 
' 
stimulated by leukotrienes (Dinarello, 1991). It may be, 
therefore, that IL-l directly modulates local weakening of 
the follicular wall, or is an indirect marker of 
inflammatory activity. After ovulation the follicular wall 
undergoes a reparative process. IL-l stimulates fibroblast 
proliferation, collagen deposition and fibrinogen formation 
(Kampschmidt, 1984i Dinarello, 1991}. In summary, IL-l is 
a potent inhibitor of FSH-induced differentiation of 
immature pig granulosa cells by inhibiting FSH-induction of 
estrogen and progesterone production, and potentiating LH-
induced cAMP generation (Yasuda et al., 1990}. 
Interferons. Another prominent cytokine present in 
follicular fluid is IFN (Grasso et al., 1988). IFN-~ is 
produced locally in the human ovary, specifically by coa+ T 
cells in theca and interstitial tissue (Grasso and 
Muscettola, 1990). It has been found that the 
administration of IFN to women with normal menstrual cycles 
reduces their serum levels of progesterone in the luteal 
phase and serum estradiol levels in the follicular phase 
without affecting gonadotropin levels (Kauppita et al., 
1982). When rat and human granulosa cells are exposed to 
IFN in vitro, an inhibition in the production of 
progesterone is observed (Gorospe et al., 1988; Wang et al., 
1992a; Fukuoka et al., 1992). IFN-a and IFN-B had a similar 
effect, but not as pronounced as IFN-~. Wang et al., 
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(1992a) reported that at a high concentration of IFN-I (1000 
U/ml) decreased both basal and hCG-stimulated progesterone 
production by human luteal cells. Treatment of rat 
granulosa cells with recombinant rat IFN-r in the presence 
of FSH, significantly inhibited FSH-stimulated aromatase 
activity and progesterone production in a dose-dependent 
manner (Xiao and Findlay, 1991). This effect was not seen 
when FSH was not present in the culture medium. It has also 
been reported that IFN-I inhibits the ability of FSH to 
induce LH and hCG for receptor formation (Grasso and 
Muscettola, 1990; Fukuoka et al., 1992}. Moreover, IFNs 
have an inhibitory effect on hCG- and FSH-stimulated cAMP 
generation in cultured rat (Xiao and Findlay, 1991) and 
human (Fukuoka et al., 1992) granulosa cells. Even though 
IFNs have inhibitory effects on progesterone secretion, it 
did not cause any changes in the human granulosa cell 
numbers or viability (Wang et al., 1992b). Therefore, IFNs 
are.potent inhibitors of progesterone and estradiol 
production, and hCG- and FSH-stimulated cAMP generation by 
rat and human granulosa cells. 
Tumor Necrosis Factor. Concentrations of TNF in bovine 
follicular fluid from early midcycle and preovulatory 
follicles, increase with days of the estrous cycle having 
its maximal concentration the day of ovulation (Fukumatzu et 
al., 1992). One day after of ovulation, while the corpus 
hemorragicum is still present, high concentrations of TNF 
can still be observed (Zolti et al., 1990). This and other 
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evidence that rat and cow granulosa cells (Roby and 
Terranova, 1988; Roby and Terranova, 1989), as well as 
thecal cells (Hurwitz et al., 1991a), contain and produce 
TNF indicate that TNF is probably a paracrine or autocrine 
mediator of theca and granulosa cell function. TNF mRNA 
expressed in rat ovary does not appear to due to the mRNA of 
white blood cells (Sanche-Tello et al., 1992}. 
Immunoreactive TNF was localized in human ovary to the 
follicular and luteal compartment (Roby et al., 1990). 
Healthy antral follicles contained TNF in the antral layer 
of granulosa cells, and a greater amount of TNF was found in 
granulosa cells {24 hr of culture) from atretic follicles 
than in healthy follicles, indicating a relationship of TNF 
with follicular atresia (Roby et al., 1990). TNF 
immunolocalization was apparent throughout the entire 
granulosa cell layer of atretic follicles, and also it 
appears to be present in the follicular fluid surrounding 
the antral and pyknotic granulosa cells (Roby et al., 1990). 
Immunoreactive (Roby and Terranova, 1989) and bioactive TNF 
in corpora lutea (Bagavandoss et al., 1990) and granulosa 
cells (Zolti et al., 1990} indicates that ovarian cells 
andjor ovarian rnacrophages are sources of TNF production. 
TNF inhibited rat (Emote and Baird, 1988; Adashi et 
al., 1989}, porcine (Veldhuis et al., 1991) and human 
(Fukuoka et al., 1992) granulosa cell progesterone 
production by about 80% compared to control. FSH increased 
basal progesterone production by rat granulosa cells, but 
29 
when TNF was present, FSH-stimulated progesterone production 
was significantly attenuated (Roby and Terranova, 1990). A 
similar inhibitory effect on progesterone production was 
observed in porcine granulosa cells exposed to TNF (Yasuda 
et al., 1990). On the other hand, other studies done with 
whole ovaries and(or) purified thecal cells, found that TNF 
stimulated rat thecal cell progesterone, 20a-
dihydroprogesterone, 17a-dihydroprogesterone, and 
androstenedione production (Roby and Terranova, 1988b; Roby 
and Terranova, 1990; Roby et al., 1990). In contrast, TNF 
was found to inhibit LH-stimulated androgen production by 
purified thecal cells (Andreani et al., 1991). Reasons for 
these discrepancies between studies is unclear. 
TNF may participate in regulation of follicular 
estrogen secretion, which could determine whether the 
follicle remains healthy or becomes atretic during its 
course of development (Roby and Terranova, 1990). In 
cul~ured rat granulosa cells, basal aromatase activity was 
very low in the absence or the presence of various 
concentrations of TNF, establishing that TNF cannot 
stimulate aromatase activity by itself (Emoto and Baird, 
1988; Adashi et al., 1989). However, TNF inhibited FSH-
induced aromatase activity in rat (Emoto and Baird, 1988; 
Adashi et al., 1989), pig (Yasuda et al., 1990), and human 
(Zolti et al., 1992) granulosa cells, having its maximum 
effect at 10 ngjml of TNF added to the culture medium. In 
vivo, this inhibitory effect on aromatase activity in 
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granulosa cells would likely cause a decrease in estrad~ol 
concentrations in the follicular fluid. Adashi et al., 
(1989) reported that TNF treatment to granulosa cells 
resulted in a decrease in the ability of FSH to increase 
extracellular cAMP which indicates that TNF may affect 
proximal cAMP generation. However, TNF did not affect FSH-
induced cAMP at sites distal to cAMP production (Roby and 
Terranova, 1990). Ernoto and Baird, (1988) indicated that 
TNF had no effect on cell protein and cell viability in the 
presence or absence of FSH, suggesting a direct effect of 
TNF on the differentiated function of the granulosa cells. 
In summary, it is thought that TNF has participation in 
follicular atresia, since it stimulates thecal progesterone 
production (Roby and Terranova, 1990), inhibits LH-
stimulated androgen production by theca (Andreani et al., 
1991} and inhibits FSH-stimulated aromatase activity in 
granulosa cells (Emoto and Baird, 1988; Adashi et al., 
1989.) . 
Cytokines in the Corpus Luteurn 
Macrophages have been identified in the corpus luteum 
from adult rats, cattle, and humans, as these cells are 
involved in the phagocytosis of luteal cells during 
luteolysis (Lobel and Levy, 1968; Roby and Terranova, 1990; 
Wang et al., 1992). Thus, IL-lB, IFN-y, and TNF as products 
of macrophages and other white blood cells, may play a role 
in the regulation of the corpus luteum. IL-1B was found to 
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be a potent stimulator of PGE2 and 6 ketoPGF1a synthesis in 
bovine luteal cells (Nothnick and Pate, 1990), indicating a 
role of IL-l in luteal PGE2 production. These 
prostaglandins are necessary for normal maturation and 
lifespan of the corpus luteum. Analysis done in bovine 
luteal cells by Benyo and Pate (1992), showed that TNF and 
IL-1B increased prostaglandin F2a (PGF~) and 6 ketoPGF1a 
production in a dose dependent manner. Similar results were 
observed when granulosa-luteal cells from humans were 
cultured in the presence of hCG (Wang et al., 1992b). These 
results suggest that IL-1B andjor TNF may play an important 
role in the maturation and lifespan of the corpus luteum 
after ovulation. No significant effect was observed in 
progesterone production, but a declining trend was observed 
when luteal cells were exposed to TNF (Benyo and Pate, 1992; 
Wang et al., 1992b). 
Cytokines in Maternal Recognition 
of Pregnancy 
In order to maintain a successful pregnancy in domestic 
mammals, the process of luteolysis has to be inhibited as 
well as the immune response from the mother to a foreign 
tissue. The conceptus is thought to be responsible for this 
signalling during the first few weeks of life. Conceptus 
signalling may be accomplished through the synthesis and 
secretion of an IFN-like polypeptide known as trophoblast 
protein-1 (Bazer et al., 1991; Hernandez-Ledezma et al., 
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1992). This protein has been identified in sheep (oTP-1), 
bovine (bTP-1}, and caprine conceptuses (Stewart et al:, 
1987; Stewart et al., 1989; Thatcher et al., 1989; Bazer et 
al., 1991; Mirando et al., 1991; Hernandez-Ledezma et al., 
1992; Geisert et al., 1992). The conceptus IFN-like protein 
which is similar to bovine IFN-aii, has antiviral activity, 
and is effective against many viruses. Because of their 
structural resemblance, oTP-1 and IFN-aii compete for same 
receptor (Stewart et al., 1987; Stewart et al., 1989; 
Roberts, 1989; Roberts et al., 1989). 
The mechanism by which oTP-1 prevent luteolysis is 
thought to be through the inhibition of endometrial PGF~ 
release in response to estrogen and oxytocin triggering, and 
by suppressing inositol phosphate/diacylglycerol second 
messenger pathways for PGF~ synthesis (Helmer et al., 1989; 
Bazer et al.,1991}. Estradiol and oxytocin are necessary 
mediators of the release of PGF2a (Bazer et al., 1991; 
Geisert et al., 1992} required for the initiation of 
luteolysis. Nonpregnant ewes that have been exposed to 
uterine infusion of oTP-1 between day 12 and day 18 have 
extended interestrous intervals through maintenance of the 
corpus luteum (Vallet et al., 1988). Another possible way 
that the inhibition of PG~a by bTP-1 or IFN-a is 
accomplished is by the stimulation of 2',5'-oligoadenylate 
synthetase activity (Mirando et al., 1991; Short et al., 
1991) . During maternal recognition of pregnancy ovarian 
follicular populations are altered in cattle (Thatcher et 
al., 1989; Spicer and Geisert, 1992). Thus, cytokines may 
play a role in the suppression of follicular development 
during this early stage of pregnancy, by reducing the 
secretion of estradiol that could otherwise stimulate 
uterine secretion of prostaglandin F~ (Thatcher et al., 
1986). In support of these suggestions, administration of 
IFN-a to women, reduced estradiol and progesterone 
concentration in blood (Kauppita et al., 1982; Newton et 
al., 1990}, and in vitro studies showed the same effect on 
luteinized human granulosa cells (Fukuoka et al., 1992). 
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The exact mechanism of how cytokines work in maternal 
recognition remains to be elucidated, but more research is 
being done and many of the questions that we have currently, 
will be answered hopefully in the near future. 
Disease Prevention and Future 
Application of Cytokines 
The immune system is composed of many signalling 
pathways for communication between cells. It has been 
demonstrated that this communication is based on proteins 
known as cytokines, produced by the immune cells (e.g., 
macrophages) that will regulate the response of the body 
toward a foreign agent or inflammatory reaction. The 
regulatory mechanism involved in modulating the immune 
system is very delicate and complex at the same time. 
Cytokines can inhibit, enhance, or overlap each other's 
function, making it hard to observe the specific function 
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that each one has. With advancement of recombinant DNA and 
other technologies, we will better be able to obtain the 
required quantities of cytokines that can be used in the 
treatment of cancer, prevention of implanted tissue 
rejection, and improvement of production efficiency in the 
animal industry. For example, Babiuk et al. (1987) 
demonstrated that intra-muscular application of IFN-~ to 
cattle suffering bovine respiratory diseases (BRD) reduces 
the clinical signs of the disease. He also showed that 
treating with IFN-r after infection was not as effective as 
when the treatment occurred prior to infection. IFN-~ can 
also be used in the prevention of intramammary infection 
(mastitis) by triggering the immune response. Because of the 
short half-life of IFN-r, and the low therapeutic doses (105 
U of IFN-r per quarter) required for beneficial effects, 
cytokines have an advantage in the control of mastitis 
(Babiuk et al. 1990) . Other cytokines such as IL-2 has been 
extensively used in the treatment of cancer (melanoma) in 
children and adult patients. TNF has been used in cancer 
treatment as well, but because of its cytotoxic effects, its 
use is just strictly for research. The administration of 
TNF-a to healthy animals {rats and cattle) induces 
cardiovascular collapse, multiorgan system failure, and 
death (Campos et al., 1991). Both passive immunization with 
antibodies to TNF-a and blockade of IL-l receptors with IL-l 
antagonist improves the survival in primates exposed to 
E.coli septic shock (Tracey et al. 1987; Fischer et al., 
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1992). 
The more open and practical use of cytokines in therapy 
will be seen in the near future, but before this, cytokines 
will have to be available in concentrations and quantities 
that doctors, patients, and producers can afford. More 
research should be done with cytokines in order to elucidate 
their practical use in human medicine and in the animal 
industry. Moreover, increased levels of cytokines, whether 
exogenously supplied or induced by disease endogenously, may 
have significant effects on reproductive functions, 
particularly ovarian steroidogenesis. Further research will 
be required to determine if cytokines mediate certain 
disease-induced reproductive failure in cattle. 
CHAPTER III 
EFFECTS OF CYTOKINES ON ESTRADIOL 
PRODUCTION BY BOVINE GRANULOSA 
CELLS IN VITRO: DEPENDENCE 
ON SIZE OF FOLLICLE 
Introduction 
cytokines not only exert effects on the immune system but 
also exert effects on ovarian follicular cell steroidogenesis 
(Adashi, 1990a; Adashi, 1990b; Hurwitz et al., 1991; Barak et 
al., 1992b). Among these cytokines, the interleukins (ILs), 
interferons (IFNs), and tumor necrosis factor a (TNF-a) have 
been shown to have inhibitory effects on estrogen production 
by rat ovarian granulosa cells cultured in vitro (Gorospe et 
al., 1988; Adashi et al., 1989; Kasson and Gorospe, 1989). The 
sou,rces of these cytokines within the ovary appear to be 
luteal (Roby and Terranova, 1989; Roby et al., 1990; Ji et 
al., 1991) and granulosa cells (Roby and Terranova, 1989; Roby 
et al., 1990} as well as white blood cells such as 
macrophages, eosinophils, leukocytes and T lymphocytes (Roby 
and Terranova, 1989; Nakamura et al., 1987; Cavender and 
Murdock, 1988; Hughes et al., 1990). Therefore, cytokines may 
act as local (paracrine or autocrine) regulators of ovarian 
function (Adashi, 199Da; Adashi, 1990b). Whether cytokines 
differentially affect granulosa cell functions in small and 
large follicles is unknown, but a recent study indicates that 
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granulosa cells from small and large follicles r~spond 
differently to conditioned medium from cultured splenocytes (a 
source of cytokines; Hughes et al., 1990). Also, reports on 
direct effects of cytokines on aromatase activity of bovine 
ovarian cells are scarce. Therefore, the objective of this 
study was to determine the effects of ILs, IFNs and TNF-a on 
in vitro cell aromatase activity of granulosa cells obtained 
from small and large bovine antral follicles. 
Materials and Methods 
Reagents and Hormones 
Reagents used in the experiments were: Dubelcco's 
Modified Eagles Medium (DMEM), Ham's F12, insulin (bovine) and 
fetal calf serum (FCS} obtained from Sigma Chemical Co. (St. 
Louis, MO); ovine FSH (NIADDK-oFSH-17, FSH activity 20 x NIH-
FSH-S1 Ujmg; LH activity 0.04 x NIH-LH-S1 Ujmg) obtained from 
the National Hormone and Pituitary Program (Baltimore, MD) 
exept for the IL-6 studies where oFSH-19 was used (USDA-oFSH-
19-SIAFP-I-2, FSH activity 94 X NIH-FSH-S1 Ujmg; LH activity 
0.025 x NIH-LH-Sl U/mg); testosterone obtained from Steraloids 
Inc. (Wilton, NH); recombinant human IFN-a (~ 4 x 108 Ujmg) 
and IL-6 (~ 0.1 ng endotoxin per ~g) were obtained from R&D 
systems (Minneapolis, MN); recombinant human IL-1B (< 0.1 ng 
endotoxin per mg), IL-2 (5 x 106 Ujmg) and TNF-a (3.2 x 107 
Ujmg) obtained from Bachem (Torrance, CA); recombinant bovine 
IFN-B2 and IFN-~ obtained from Genentech, Inc. (South San 
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Francisco, CA); and recombinant bovine trophoblast protein-1 
(bTP-1; 1.5 x 107 Ujmg; generously donated by Dr. R. Michael 
Roberts, University of Missouri, Columbia, MO). 
Cell Culture 
ovaries were obtained from Quality Meats slaughter house 
(Wellington, KS) from beef, dairy cows, and heifers after 
slaughter. ovaries were placed in saline solution (0.15 M 
NaCl), transported to the laboratory on ice (< 120 min), 
washed three times in saline solution (0.15 M NaCl), and then 
rinsed in ethanol solution (70% ETOH:30% saline solution) for 
30 seconds and followed by rinsing three times with saline 
solution. Follicles were separated into two groups based on 
surface diameter: small (1 to 5 mm; containing mainly 
undifferentiated granulosa cells) and large (~ 8 mm; 
containing mainly differentiated granulosa cells) as 
previously described (Langhout et al., 1991). Granulosa cells 
were collected by aspiration using a needle (20 gauge, 38.1 
mm) and syringe (plastic, 3 ml) and washed twice in serum-free 
medium via centrifugation (100 X g for 5 min). Medium was a 
1:1 mixture of DMEM and Ham's F12 containing 0.12 mM 
gentamicin and 38.5 mM sodium bicarbonate. Number of viable 
cells (24 ± 2% and 33 ± 4% of total cells obtained from small 
and large follicles, respectively) were determined using the 
trypan blue exclusion method (Adashi et al., 1987). Between 
1 and 3 x 105 cells in 30 to 80 ~1 of medium were added to 
Falcon multiwell plates (#3047; Becton Dickinson and Co., 
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Oxnard, Ca.) containing 1 ml medium. Cultures were k7pt at 
37°C in a 5% C02 atmosphere, and medium was changed every 24 
has described by Langhout et al., (1991). To obtain optimal 
attachment, cells were maintained in the presence of 10% FCS 
for the first 2 days of culture, unless stated otherwise. 
After the attachment period, granulosa cells were washed twice 
with 0.5 ml serum-free medium and incubations continued in 
serum-free medium with or without hormones. For studies 
evaluating the effect of hormones on aromatase activity, 
hormonal treatments were applied for 1 day (i.e., day 2 to 3 
of culture), unless stated otherwise. 
Determination of Granulosa Cell Number 
Numbers of granulosa cell were determined at the 
termination of experiments using a Coulter counter (Model Zm; 
Coulter Electronics, Haileah, FL) as previously described by 
Baranao and Hammond, (1985) and Langhout et al., (1991). 
Briefly, cells were exposed to 0.5 ml of trypsin (0.25% 
wtjvol) for 20 min at 25°C, then scraped from each well with 
a teflon policeman, diluted in 0.15 M NaCl and enumerated. 
Cell Viability 
Viability of granulosa cells were determined at the 
beginning of the culture period and after 3 days in culture by 




Concentrations of estradiol-178 in culture medium were 
determined by radioimmunoassay (RIA) as previously described 
(Spicer and Enright, 1991). The intra- and interassay CV were 
12 and 20%, respectively. Cross-reactivity for estrone and 
estradiol-17a expressed relative to estradiol-178, were 1.3% 
and 3. 4%, respectively, as previously described (Cox and 
Britt, 1982). The doses of testosterone and the other 
hormones used did not crossreact in the RIA. 
Statistical Analyses 
Experimental data are presented as the least squares 
means ± SE of measurements from quadruplicate culture wells 
from two or more experiments. Each experiment was performed 
two to four times with different pools of granulosa cells 
collected from 20 to 60 ovaries for each pool. Only two 
experiments were performed if results from each experiment 
were in agreement with each other. Treatment effects and 
interactions were assessed using GLM procedures of SAS (SAS, 
1988). Main effects were treatment (e.g., dose) and 
experiment 
analyzed. 
when data from more than one experiment were 
Each well was a replicate and each experiment 
contained four replicates per treatment. When estradiol was 
expressed as (pg/105 cells/24 h) 1 cell numbers at the 
termination of the experiment were used for this calculation. 
Specific differences in cell growth and arornatase activity 
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between treatments were determined using Fisher's Pro~ected 
Least Significant Difference Procedure (Ott, 1977) . 
Results 
Assessment of Functional Aromatase Activity 
Functional aromatase activity was determined during a 24-
h exposure of granulosa cells to testosterone (1 or 3 ~gjml) 
as an estradiol precursor. These doses were maximal for 
estradiol production after 24-h incubation (data not shown) . 
Conversion of testosterone to estradiol was time dependent and 
increased linearly from 4 to 24 h of incubation (Figure 1) and 
proportional to the number of cells (0.5 to 12 x 105 
cellsjwell) plated (data not shown). To optimize hormonally 
sensitive aromatase activity in culture, granulosa cells were 
obtained from small and large follicles, cultured for either 
1 or 2 days in the presence of 10% FCS and then treated with 
insulin (5 ~g/ml) and(or) FSH (200 ngjml) for an additional 24 
h in the presence of 3 ~g/ml testosterone. In cells from 
small and large follicles neither insulin nor FSH affected 
estradiol production of cells cultured for only 1 day with 10% 
FCS (Figure 2). Estradiol production was greater (P<.OS) in 
cells from large follicles than that of small follicles on Day 
1-2 of culture. Also, estradiol production decreased between 
Day 1-2 and Day 2-3 in control cells from small and large 
follicles and in insulin-treated cells from large follicles 
42 
{Figure 2). Insulin alone increased (P<.05) est~adiol 
production by cells from small follicles but not by cells from 
large follicles. However, FSH increased (P<.05) estradiol 
production in the presence of insulin in cells from both small 
and large follicles. Thus, cultures in which cells were 
exposed for 2 days with 10% FCS and 1 day with hormones (1 
~gjml insulin and 200 ngjml FSH) and 1 ~gjml testosterone were 
selected as optimal conditions for further experiments to 
evaluate estradiol production. 
Effect of IL-1B, IL-2 and IL-6 on FSH-induced 
Granulosa Cell Estradiol Production 
To determine the effect of IL-18, IL-2 and IL-6 on FSH-
induced estradiol production by bovine granulosa cells, cells 
were obtained from small and large follicles, cultured for 48 
h in 10% FCS, and then cultured in the presence of FSH (50 or 
200 ngjml), insulin (1 ~gjml) and testosterone (1 ~g/ml) for 
additional 24 h to maximize arornatase activity. During these 
24 h, treatment of IL-18 (0, 10 and 100 ngjml), IL-2 (0 and 
100 ngjml) and IL-6 (0, 0.1, 1.0, 10.0, 30.0, and 100.0 ngjml) 
were added to the culture medium. In cultures of granulosa 
cells from large follicles, IL-1B, IL-2, and IL-6 {0.1 to 10.0 
ngjml) had no significant effect on FSH-induced estradiol 
production {Figures 3 and 4), whereas 30 and 100 ngjml of IL-
6 inhibited FSH-induced estradiol production by 62 and 50%, 
respectively (Figure 4). The ID50 for IL-6 was approximately 
25 ngjml for cells from large follicles. In cultures of 
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granulosa cells from small follicles, 100 ngjml of IL~lB and 
IL-2 inhibited FSH-induced estradiol production by 31% and 
45%, respectively while 10 ngjml of IL-lB had no significant 
effect (P>.05) (Figure 3). All doses of IL-6 inhibited 
(P<. 05) FSH-induced estradiol production with maximal 
inhibition achieved (75% decrease) with ~ 10 ngjml (Figure 5). 
ID50 for IL-6 was approximately 1. o ngjml for cells from small 
follicles. IL-lB had no effect on cell numbers (Table 1) . 
IL-2 reduced cell numbers by 27% in cultures of cells from 
small follicles (Table 1), but had no effect on cell viability 
(Table 2). At 100 ngjml, IL-6 decreased (P<.OS) numbers of 
cells from large follicles, and 1 to 100 ngjml of IL-6 reduced 
(P<. 05) cell numbers by 25 to 55 % in cells from small 
follicles (Figure 6). 
Effect of Interferons on FSH-induced Granulosa Cell 
Estradiol Production 
In cultures of granulosa cells from large follicles, 10 
and 100 Ufml of IFN-B and 100 U/ml of IFN-r had no effect 
(P>.05} on FSH-induced estradiol production (Figure 7). In 
contrast, 100 Ufml of IFN-B and IFN-r inhibited (P<.05) FSH-
induced estradiol production by 47% and 71%, respectively, in 
cultures of granulosa cells from small follicles; 10 Ujml of 
IFN-B had no significant effect (Figure 7). IFN-a at 10 and 
100 U/ml inhibited (P<. 05) FSH-induced estradiol production by 
18% and 22%, respectively in cultures of granulosa cells from 
large follicles, and by 20% and 61%, respectively in cultures 
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TABLE 1 
EFFECT OF CYTOKINES (24 h TREATf.fENT) ON NUMBERS 
OF GRANULOSA CELLS COLLECTED FROM SMALL (1-5mm) 
AND LARGE {~ 8mm) FOLLICLES 
Cell number (% of control) 
cytokine Dose Small Follicles• Large Follicles6 
IL-113 10 97.7 ± 4.7 102.1 ± 2.8 
100 100.9 ± 4.7 107.1 ± 2.8 
IL-2 100 *73.1 ± 5.6 94.9 ± 3.7 
TN F-a 10 94.8 ± 5.2 112.6 ± 4.5 
100 99.5 ± 5.2 99.4 ± 4.5 
IFN-a 10 93.3 ± 4.9 82.3 ± 4.6 
100 *79.9 ± 4.9 91.5 ± 4.2 
IFN-8 10 94.8 ± 6.0 100.7 ± 5.9 
100 92.1 ± 6.0 98.1 ± 6.1 
IFN-'Y 100 98.8 ± 5.9 121.1 ± 13.8 
bTP-1 10 120.0 ± 8.7 118.4 ± 5.3 
100 96.0 ± 8.7 114.3 ± 4.5 
"Data are mean ± SE of 2 separate experiments for each 
cytokine; averaged across experiments, control cultures 
averaged 0.94 ± .05 x 105 cellsjwell. *P<.05 vs controls. 
bData are means ± SE of 3 separate experiments for each 
cytokine; averaged across experiments, control cultures 
averaged 0.20 ± .01 x 105 cellfwell. *P<.05 vs controls. 
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of cells from small follicles (Figure 7). IFN-B and IF~-r had 
no effect on cell numbers (Table 1). IFN-a (100 U/ml) reduced 
cell numbers by 20% in cultures of cells from small follicles 
only, but had no effect on cell viability (Table 2). 
Bovine trophoblast protein-1 (bTP-1), which is an 
interferon-like protein produced by the conceptus, was also 
tested and found to have no effect (P>. 05) on FSH-induced 
estradiol production by cultures of cells from large follicles 
(Figure 8). However, 100 U/ml bTP-1 inhibited (P<.05) FSH-
induced estradiol production by cells from small follicles by 
28% whereas 10 U/ml was without effect (Figure 8). 
Effect of TNF-a on FSH-induced Granulosa Cell 
Estradiol Production 
TNF-a had no effect (P>. 05) on FSH-induced estradiol 
production by granulosa cells from large follicles when 10 and 
100 ngjml were applied (Figure 8). In contrast, 10 and 100 
ngjml of TNF-a inhibited (P<.05) FSH-induced estradiol 
production by 65% and 72%, respectively, in cultures of 
granulosa cells from small follicles (Figure 8) . TNF-a had no 
effect on cell numbers (Table 1) or cell viability (Table 2). 
TABLE 2 
EFFECT OF CYTOKINES (24 h TREATMENT) ON VIABILITY OF 








CELL VIABILITY {%)a 
95.2 ± 1.4 
97.6 ± 1.4 
96.8 ± 1.3 
97.6 ± 1.4 
98.5 ± 1.5 
98.2 ± 1.5 





The results from the present studies indicate that 
cytokines have little or no effect on FSH-induced estradiol 
production by granulosa cells collected from large bovine 
follicles. In contrast to large follicles, cytokines have 
potent inhibitory effects on FSH-induced estradiol production 
by granulosa cells from small bovine follicles. 
IL-lB decreased FSH-induced estradiol production by 
granulosa cells from small follicles by 30% in the present 
study. This finding is in general agreement with Gottschall 
et al., ( 1989) and Kasson and Gorospe, ( 1989) who observed 
that IL-B and (or) IL-a decreased FSH-induced estradiol 
production by 20% to 80% in granulosa cells from rat ovaries. 
Yasuda et al., ( 1990) observed similar effects of IL-l on 
cultured porcine granulosa cells. Barak et al., (1992a) found 
that IL-l inhibited hCG-stirnulated aromatase activity and 
estradiol production by human granulosa cells. In addition 
hCG-stirnulated granulosa cell progesterone production was 
decreased by a specific IL-l inhibitor (Barak et al., 1992a). 
No effect was observed of IL-lB or IL-2 in FSH-induced 
estradiol production by granulosa cells from large bovine 
follicles in the present study. Reasons for the discrepancies 
are unclear but may be do to the species differences and (or) 
differentiative state of the granulosa cell used for cell 
culture. Alternatively, varying levels of endotoxin in the 
various preparations of cytokines may contribute to 
differences in results among studies. In vitro, IL-2 has also 
48 
been shown to inhibit hCG-induced progesterone produc~ion by 
human granulosa-luteal cells (Wang et al., 1991) but stimulate 
(Kasson and Gorospe, 1989) or have no effect (Gottschall et 
al., 1988) on FSH-induced progesterone production by rat 
granulosa cells. In the present study, IL-6 decreased FSH-
induced estradiol production by granulosa cells from small and 
large follicles by 75 and 62%, respectively. This is in 
agreement with others who observed that IL-6 inhibited FSH-
induced progesterone production by rat granulosa cells 
(Gorospe et al., 1992). To our knowledge, no previous study 
has evaluated the effect of IL-6 on granulosa cell estradiol 
production. Collectively, these results indicate that IL-1B 
inhibits FSH-induced estrogen production by granulosa cells 
regardless of species, whereas IL-2 inhibition of aromatase 
activity may be species-dependent. At present, it is unclear 
if species differences exist relative to effect of IL-6. our 
studies also indicate that granulosa cell responsiveness to 
cyt,okines is dependent on size of follicle. Similarly, 
previous studies have indicated that granulosa cells from 
small porcine follicles respond to conditioned medium from 
cultured splenocytes (a source of cytokines) differently than 
granulosa cells from large porcine follicles (Hughes et al., 
1990). Why granulosa cells from large bovine follicles are 
less sensitive to ILs than cells from small follicles is 
unclear. Perhaps highly differentiated granulosa cells (large 
follicles) contain much fewer or no receptors for ILs than 
undifferentiated granulosa cells (small follicles). Further 
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research is needed to verify this suggestion. 
The inhibitory effect of IL-6 of proliferation of 
granulosa cells has not been reported previously; this 
inhibitory effect of IL-6 was more pronounced in cultures of 
cells from small than large follicles and was observed using 
serum-free as well as serum-containing medium (data not 
shown). Yasuda et al., (1992) found that interferon inhibited 
porcine granulosa cell proliferation in a dose-dependent 
manner. In contrast, others observed that tumor necrosis 
factor-a (TNF-a:) stimulated proliferatiion of human granulosa-
luteal cells (Yan et al., 1993) and porcine granulosa cells 
(Fukuoka et al., 1992) in a dose-dependent manner. Fukuoka et 
al., ( 1992) also observed a stimulatory effect of IL-l on 
proliferation of porcine granulosa cells whereas IL-2 was 
without effect. On the other hand, in the present study IL-2 
caused a significant inhibitory effect (27%) on cell 
proliferation of bovine granulosa cells from small follicles. 
Others working with rat granulosa cells observed no effect of 
TNF-a: on cell proliferation (Darbon et al., 1989). Reasons 
for the discrepancies among studies on the effect of cytokines 
on granulosa cell proliferation is unclear, but may be due to 
the specific cytokine tested, species differences, and(or) 
differentiati ve state of the granulosa cell used for cell 
culture. Furthermore, because 1 and 100 ngjml of IL-6 reduced 
cell number by 26 and 55%, respectively, and estradiol 
production was corrected for cell numbers, the inhibitory 
effect of IL-6 on estradiol production was not soley due to 
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decreased cell numbers. Whether viability· of ce~ls is 
affected by IL-6 was not determined in the present study and 
may account for some of the inhibitory effects of IL-6. This 
possibility will require additional experimentation. 
In agreement with a previous study using rat granulosa 
cells (Gorospe et al., 1988), we observed an inhibitory (71% 
decrease} effect of IFN-~ on FSH-induced estradiol production 
by bovine granulosa cells. IFN-~ has also been shown to 
inhibit progesterone production by cultured bovine luteal 
cells (Fairchild and Pate, 1991) . In addition, we observed 
significant inhibitory effects (20% to 61% decrease) of IFN-a 
on FSH-induced estradiol production by granulosa cells from 
small and large follicles. This is in contrast with other 
studies that showed no effect of IFN-a on FSH-induced 
estradiol production in rat granulosa cells (Gorospe et al., 
1988; Adashi et al., 1989}. Reasons for these differences are 
unknown but are likely due to species differences. 
The present study also showed that IFN-B and bTP-1 can 
decrease FSH-induced estradiol production by 47% and 28%, 
respectively in cultured bovine granulosa cells. Previous 
studies have not evaluated the effect of these two interferon-
like cytokines on aromatase activity of granulosa cells. It 
was recently reported that estradiol concentrations in 
follicular fluid are significantly decreased in large (~ 8 mm) 
follicles on day 15 and 18 of pregnancy in cattle (Spicer and 
Geisert, 1992}, suggesting that the presence of a developing 
conceptus early in pregnancy may inhibit follicular estradiol 
51 
production. Thus, we hypothesize that interferons, p~oduced 
by the conceptus and (or) the conceptus-stimulated uterus, may 
promote luteal function in early pregnant cows by inhibiting 
follicular estrogen production, which is known to be involved 
in luteolysis of ruminant species (Niswender and Nett, 1988; 
Spicer and Geisert, 1992). 
TNF-a decreased FSH-induced estradiol production by 
granulosa cells from small follicles by 72% in the present 
study. This is in agreement with others which found a potent 
(70%) inhibitory effect of TNF-a on estradiol production by 
rat granulosa cells (Adashi et al., 1989; Emote and Baird, 
1988). It has been found that TNF-a decreases progesterone 
production by rat granulosa cells (Darbon et al., 1989; Adashi 
et al., 1990; Roby and Terranova, 1990) and by bovine luteal 
cells (Benyo and Pate, 1992) in vitro. Moreover, it has been 
demonstrated that TNF-a does not affect cell numbers or 
viability (present study; Gorospe et al., 1988; Adashi et al., 
1989) giving then, the possibility of another mechanism of 
action. TNF-a and IL-l appear to act at the site of cAMP 
generation, inhibiting FSH-induced cAMP formation (Gottschall 
et al., 1988; Adashi et al., 1989; Darbon et al., 1989). 
Similar to other studies with porcine granulosa cells 
(Haney and Schomberg, 1981; Stoklosowa et al., 1982), we 
observed a decrease in estradiol production with increased 
duration of culture. This decrease in estradiol production 
was more pronounced in cells from large follicles. As 
previously demonstrated (Haney and Schomberg, 1981; Anderson 
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et al., 1979), granulosa cells from large follicles ini,tially 
had more aromatase activity than did cells from small 
follicles. In agreement with previous findings using porcine 
granulosa cells (May and Schomberg, 1981; Maruo et al., 1988), 
we observed an increase in FSH-induced estradiol production by 
bovine granulosa cells treated with insulin. 
The cellular source of ovarian cytokines is uncertain, 
but may include blood-borne lymphocytes, leukocytes, 
rnacrophages and other immune cells (Nakamura et al., 1987; 
Cavender and Murdoch, 1988). Previous studies have shown that 
these cells infiltrate the follicular theca shortly after the 
LH surge (Nakamura et al. 1 1987; Cavender and Murdoch 1 1988) 1 
that rat ovaries contain TNF-a mRNA (Sancho-Tello et al., 
1992) and IL-lB mRNA (Hurwitz et al. 1 1991) 1 that human 
follicular fluid contains macrophages (Loukides et al. 1 1990) 1 
that bovine (Zolti et al. 1 1990) and human (Zolti et al., 
1992) follicular fluid contains TNF-like activity, and that 
human follicular fluid contains measurable IL-6 levels 
(Buyalos et al., 1992) . The levels of TNF-a in bovine 
follicular fluid (5 to 10 Ujml; Zolti et al. 1 1990) and IL-6 
in human follicles (Buyalos et al., 1992} are similar to the 
lower effective dose of TNF-a and IL-6 tested in the present 
study. Alternatively, granulosa cells and luteal cells may 
produce cytokines, since TNF-a has been immunocytochemically 
localized within human (Roby and Terranova, 1990), rat (Roby 
and Terranova, 1989), and bovine (Roby and Terranova, 1989) 
granulosa cells, and bovine corpora lutea contain TNF-a mRNA 
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(Ji et al., 1991). In addition, rat granulosa cells ~ecrete 
IL-6 when cultured in vitro (Gorospe et al., 1992). Thus, 
cytokines may act as autocrine or paracrine regulators of 
ovarian follicular function. Whether the effects of cytokines 
on estradiol production 
ones are due to the 
in the present study and in previous 
direct action of cytokines on the 
granulosa cells or due to the indirect effects via production 
of additional cytokines or factors by granulosa cells is 
unknown. Such possibilities will require further study. In 
addition, studies are required to elucidate the function of 
cytokines in the reproductive process in vivo. 
In conclusion, we suggest that granulosa cells of small 
antral follicles are much more sensitive to the inhibitory 
effects of cytokines on aromatase activity and cell 
proliferation than cells from large antral follicles in 
cattle. This may provide an autocrine or paracrine mechanism 
whereby higher TNF-a activity in large follicles (Zolti et 
al., 1990) and a greater number of immune cells within large 
follicles {Nakamura et al., 1987) and regressing corpora lutea 
(Lei et al., 1991; Standaert et al., 1991) may inhibit 
estradiol production (i.e., differentiation) by smaller 
follicles, thus avoiding premature differentiation of future 
ovulatory follicles. During pregnancy, this inhibition of 
follicular estradiol production by cytokines may help maintain 
luteal function. 
Figure 1. Effect of incubation time on insulin-stimulated 
conversion of testosterone into estradiol. Cells 
from small follicles were cultured for 2 days in 
the presence of 10% FCS. During the last 4, 8 or 
24 h of culture, serum free medium containing 3 
Mgfml testosterone was added concomitantly with 
5 Mgfml insulin. Estradiol concentrations in 
medium and cell numbers were determined. Values 
are means of quadruplicate culture wells from two 
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Figure 2. Effects of insulin and(or) FSH on estradiol 
production by granulosa cells from large (Panel 
A) or small (Panel B) follicles. Granulosa cells 
were cultured for either 1 d or 2 d in the 
presence of 10% FCS and then treated with insulin 
(5 ~gjml) and(or) FSH (200 ngjml) for an 
additional 24 h in the presence of 3 J.Lg/ml 
testosterone. Values are least squares means of 
quadruplicate culture wells from two separate 
experiments. *, Mean differs (P<.05) from Day 2 
value. **, Mean differs from control value. 
Pooled SE=B and 10 pg/105 cells/24 h for Panels 
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Figure 3. Dose-response of IL-1B and IL-2 on estradiol 
production by granulosa cells collected from 
large (Panel A) and small (Panel B) follicles. 
Granulosa cells were cultured for 2 d in the 
presence of 10% FCS and then treated with 200 
ngfml FSH, 1 ~gjml insulin and 1 ~gjml 
testosterone with or without the various doses of 
cytokines for an additional 24 h. Values are 
means of quadruplicate culture wells from three 
separate experiments for Panel A and two separate 
experiments for Panel B, and are expressed as 
percentage of control cultures which averaged 89 
± 6 and 65 ± 5 pg/105 cells/24 h for Panels A and 
B, respectively. *, Mean differs (P<.05) from 
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Figure 4. Effect of IL-6 on FSH-induced estradiol production 
by granulosa cells collected from large 
follicles. Granulosa cells were cultured for 2 
days in the presence of 10% FCS as described in 
Materials and Methods, and then treated with 50 
ngjml FSH, 1 ~gjml insulin and 1 ~g/ml 
testosterone with or without the various doses of 
cytokines for an additional 24 h. Values are 
means from three separate experiments, and are 
expressed as percentage of control cultures which 
averaged 119 ± 11 pg/105 cells/24 h. a,b,~eans 
with different superscripts differ (P<.05). 
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Figure 5. Effects of IL-6 on FSH-induced estradiol production 
by granulosa cells collected from small 
follicles. Cells were cultured as described in 
Figure 4. Values are means from three separate 
experiments, and are expressed as percentage of 
control cultures which averaged 90 ± 12 pg/105 
cells/24 h. a,b,c,'Neans with different 
superscript differ (P<.05). 
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Figure 6. Effect of IL-6 on in vitro proliferation of 
granulosa cells collected from large ( ) and 
small ( .... ) follicles. Cells were cultured as 
described in Figure 4. Values are means of three 
separate experiments, and are expressed as a 
percentage of control cultures which averaged 
0. 45 ± . 03 and 1. 25 ± . 06 x 105 celljwell for 
large and small follicles, respectively. 
a,b,c,dwi thin follicles size, means with different 
superscripts differ (P<.05). 
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Figure 7. Dose-response of IFN-a IFN-B and IFN-~ on estradiol 
production by granulosa cells collected from 
large (Panel A) and small (Panel B) follicles. 
Cells were cultured as described in legend for 
Figure 3. Values are means of quadruplicate 
culture wells from two separate experiments for 
Panel A and B, and are expressed as percentage of 
control cultures which averaged 103 ± 10 and 60 
± 4 pg/105 cell/24 h for Panels A and B, 
respectively. *, Mean differs (P<.05) from 
control value (0 U/ml). 
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Figure 8. Effects of bovine trophoblast protein-1 (bTP-
-1 in U/ml) and TNF-a (ngjml) on estradiol 
production by granulosa cells collected from 
large (Panel A) and small (Panel B) follicles. 
Cells were cultured as described in legend for 
Figure 3. Values are means of quadruplicate 
culture wells from three separate experiments for 
large follicles and two separate experiments for 
small follicles, and are expressed as percentage 
of control cultures which averaged 91 ± 6 and 61 
± 4 pg/105 cells/24 h for large and small 
follicles, respectively. *,Mean differs (P<.05) 
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CHAPTER IV 
GENERAL DISCUSSION 
The immune system is regulated by glycoproteins produced 
by white blood cells such as macrophages, T lymphocytes, B 
lymphocytes, granulocytes and others. These glycoproteins are 
collectively called cytokines. They participate in 
inflammatory reactions and in the general immune response. 
The presence of white blood cells in porcine, rat, human and 
bovine ovaries during fQllicular and luteal phases has been 
reported by numerous studies. It is of great interest to 
observe the action of these white blood cells in the ovary as 
well as the possible effects that their products might have on 
folliculogenesis and steroidogenesis and therefore in 
reproduction. 
Taking into consideration the presence of white blood 
cells in the ovary and their production of cytokines, as well 
as the production of some cytokines (IFNs and TNF-a) in the 
ovary itself, we might speculate about the possible ways by 
which cytokines may be affecting the reproductive system in 
vivo. Some authors suggested that cytokines may be involved 
in the ovulatory process, differentiation of follicular tissue 
during luteinization, luteal regression and follicular 
atresia. Some of the cytokines produced by white blood cells 
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mentioned in this report are interleukins (IL-l, IL-2, IL-6), 
interferons (IFN-a, B, ~) and tumor necrosis factor-a (TNF-a) 
which may have an autocrine and (or) paracrine function in the 
various ovarian cells. First of all, the ovulatory process 
is considered to be a modified inflammatory process that is 
thought to happened by a weakening of the follicular wall. 
IL-l may be involved in the ovulatory process since IL-l 
stimulates the production of prostaglandin E2 (PGE2 ) which has 
a luteotropic effect and it is necessary for the normal 
maturation of the corpora lutea. After ovulation the 
follicular wall undergoes a reparative process. IL-l also 
exerts its action during this period through the stimulation 
of fibroblast proliferation, collagen deposition and 
fibrinogen formation that are known to be present in tissue 
during reparative processes after an inflammatory reaction. 
It has been observed that these cytokines may have an 
inhibitory effect on estradiol production through the 
inhibition of aromatase activity which is necessary in the 
transformation of testosterone to estradiol by granulosa cells 
in conjunction with thecal cells when these cells have been 
cultured. It has been shown also that cytokines can inhibit 
progesterone production by human granulosa cells and the in 
vivo treatment of IFN-~ to women causes a decrease of serum 
levels of progesterone and estradiol. Follicular growth and 
therefore cell differentiation are directly affected by the 
presence of estradiol during the follicular phase. During 
early pregnancy, this growth has to be inhibited in order to 
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maintain the corpora lutea for further pregnancy. ~aternal 
recognition of pregnancy in ruminants is also thought to 
involve an interferon-like protein, which inhibits the 
secretion of endometrial prostaglandin F2a which acts as a 
luteolysin. It can be thought that this IFN-like protein may 
induce the production of other cytokines as well, 
affect the folliculogenesis during early pregnancy. 
that may 
IL-l and 
IFNs corning from the conceptus may inhibit the growth of small 
follicles by the suppression of aromatase activity, androgen 
and estradiol production, as well as a possible decrease in 
granulosa cells in the follicle, causing low levels of 
estradiol inhibiting growth of possible ovulatory follicles 
allowing a better environment for the corpora lutea to 
maintain its full function. 
Another normal process in the ovary is the atresia of the 
follicles that are not destine to ovulate. TNF may play an 
important role in follicular atresia. TNF been found in 
pyknotic granulosa cells undergoing atresia. Its specific 
role in this process is not known yet, but we can speculate 
that TNF is involved in the triggering of apoptosis and in the 
further degeneration of the follicles as well as in the 
regression of corpora lutea. Further experimentation is 
needed before any of these cytokines can be used in the 
treatment and(or) prevention of reproductive disorders such 
asovarian cysts and miscarriage during the recognition of 
pregnancy of ruminants. 
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